Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
์ข
๋ชฉ ์ฝ๋ TNDM
ํ์ฌ ์ด๋ฆTandem Diabetes Care Inc
์์ฅ์ผNov 13, 2013
CEOMr. John F. Sheridan
์ง์ ์2650
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃNov 13
์ฃผ์12400 High Bluff Drive
๋์SAN DIEGO
์ฆ๊ถ ๊ฑฐ๋์NASDAQ Global Market Consolidated
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ92130
์ ํ18583666900
์น์ฌ์ดํธhttps://www.tandemdiabetes.com/
์ข
๋ชฉ ์ฝ๋ TNDM
์์ฅ์ผNov 13, 2013
CEOMr. John F. Sheridan
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์